This explains why some patients experience: Temporary bloating or joint discomfort from fluid shifts Increased hunger due to ghrelin pathway activation Changes in blood sugar regulation in susceptible individuals Patients with diabetes, insulin resistance, or other metabolic conditions require medical evaluation and appropriate monitoring before and during treatment
Data analysed by two-way repeated measures ANOVA to assess main effect effects of treatment ( b , c , f , g , j , k and m ) and two-way ANOVA, multiple comparison, Bonferroni post hoc test ( h )
And at higher doses, GLP-1s have been effective for weight loss ultimately by decreasing appetite and thereby restricting calorie intake
D.ZhaoZ.MaQ.WinklerE
As more data has become available, scientists have taken a closer look at how GLP-1 receptor agonists affect the brain
PubMed Knudsen, L.B., & Lau, J